Phase II Study of Gefitinib as a First-Line Therapy in Elderly Patients With Lung Adenocarcinoma (WJTOG 0402-DI): O-6–02


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles